Alembic Pharmaceuticals Ltd.

Market Capital
₹10,870 Cr.
P/E
31.73
Share Price
₹ 554.05 0.2 (0.04%)

Alembic Pharmaceuticals Ltd.

Quick View
₹ 554.05 0.2 (0.04%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
ROE has decreased vs 10 year trend
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a premium to 3yr historic valuations
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Share price
Share price has increased over last 10 years due to earnings
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has been buying shares from the open market over last 90 days
Retail Holding
Retail has been selling the stock which is usually a good time to buy
ROE
Latest
9.95%
3yr Average
19.44%
5yr Average
19.68%
Net Profit Margin
Latest
9.82%
3yr Average
16.36%
5yr Average
15.42%
ROCE
Latest
11.81%
3yr Average
20.86%
5yr Average
21.08%
Debt to Equity
Latest
0.12
3yr Average
0.25
5yr Average
0.3
Market Share
0.85% (as of Jul 22)
Anti - Diabetes - Market Share
2.04% (as of Jul 22)
Anti-Infectives - Market Share
0.14% (as of Nov 21)
Anti-Malarial - Market Share
0.01% (as of Nov 21)
Antineo Plastic - Market Share
0.26% (as of Nov 21)
Blood Related - Market Share
1.38% (as of Jul 22)
Cardiovascular - Market Share
4.40% (as of Sep 22)
Cold & Cough Medication Market Share
locked Source
0.34% (as of Nov 21)
Dermatology - Market Share
0.02% (as of Nov 21)
Endocrinology - Market Share
1.03% (as of Jul 22)
Gastro-Intestinal - Market Share
2.56% (as of Nov 21)
Gynecology - Market Share
0.10% (as of Nov 21)
Neurological - Market Share
1.26% (as of Nov 21)
Ophthalmology - Market Share
0.83% (as of Nov 21)
Pain - Market Share
1.50% (as of Dec 22)
Pharmaceutical Sector - Market Share
1.85% (as of Nov 21)
Respiratory - Market Share
3.67% (as of Nov 21)
Urology - Market Share
0.80% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -Formulations

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -API

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Formulations

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic -Formulations

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (No)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Approved by Canada
      Source
    • Number of ANDA's Filed in Australia
      Source
    • Number of ANDA's Approved by Australia
      Source
    • Number of ANDA's Filed in USA (Nos)
      Source
    • Number of ANDA's Approved By USFDA (Nos)
      Source
    • Number of ANDA's Filed in Latam
      Source
    • Number of ANDA's Approved by Latam
      Source
    • Number of ANDA's Filed in South Africa
      Source
    • Number of ANDA's Approved by South Africa
      Source
    • R&D as a % of Total Sales (%)
      Source
    • Management Compensation as a % of Sales (%)
    Peer Comparison
    Brands
    Azithral
    Tellzy
    Zeet
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Alembic Pharmaceuticals Ltd.
    View the discussion on ValuePickr
    Corporate Governance Issues At Paushak - Smart Sync Services
    Chemical Sector
    Chemicals Sector - Breakdown and Value Chain - PPFAS
    Chemical Industry - Top Down - Capital Mind
    Battery Chemistry Of EV's - Value Educator
    Indian agrichemical overview - a sectoral perspective - ValuePickr
    Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan
    Pharmaceutical Sector
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    How The Pharma Industry Works - PPFAS
    timeline
    Sign Up for Free